Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CHEK2 |
Variant | F169Lfs*2 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | CHEK2 F169Lfs*2 indicates a shift in the reading frame starting at amino acid 169 and terminating 2 residues downstream causing a premature truncation of the 543 amino acid Chek2 protein (UniProt.org). F169Lfs*2 results in reduced Kap1 phosphorylation upon ionizing radiation in cell culture (PMID: 34903604), and therefore, is predicted to lead to a loss of Chek2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 F169Lfs*2 |
Transcript | NM_007194.4 |
gDNA | chr22:g.28725064delA |
cDNA | c.507delT |
Protein | p.F169Lfs*2 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_007194.3 | chr22:g.28725064delA | c.507delT | p.F169Lfs*2 | RefSeq | GRCh38/hg38 |
NM_007194.4 | chr22:g.28725064delA | c.507delT | p.F169Lfs*2 | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28725064delA | c.507delT | p.F169Lfs*2 | RefSeq | GRCh38/hg38 |
NM_145862.2 | chr22:g.28725064delA | c.507delT | p.F169Lfs*2 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|